Journal ArticleOPEN ACCESS

Therapeutics and COVID-19—A living WHO guideline: Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine

Acta Anaesthesiologica Scandinavica (2022) 66(5) 636-637
DOI: 10.1111/aas.14046
4Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The Clinical Practice Committee of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine endorses the Living WHO guideline on therapeutics and COVID-19. This trustworthy continuously updated guideline serves as a highly useful decision aid for Nordic anaesthesiologists caring for patients with COVID-19.

Author supplied keywords

Cite

CITATION STYLE

APA

Møller, M. H., Chew, M. S., Olkkola, K. T., Rehn, M., Yli-Hankala, A., & Sigurðsson, M. I. (2022). Therapeutics and COVID-19—A living WHO guideline: Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine. Acta Anaesthesiologica Scandinavica, 66(5), 636–637. https://doi.org/10.1111/aas.14046

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free